AIATELLA key facts
as of Oct 2026- Developer of cloud-based medical software designed to address the global healthcare crisis of increasing imaging volumes and specialist shortages.
- AIATELLA is valued at approximately $6.1M as of Oct 2026 (last reported valuation).
- It has raised $2.3M; the latest was Early Stage VC ($2.3M) in May 2025.
- Notable investors include Business Finland, Harjavalta, Accelerating FemTech, Instrumentarium Science Foundation, MDJD Investments — 7 tracked in total.
- Status: Privately Held (backing).
AIATELLA's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch AIATELLA: the Monday email on marks, rounds and moves
AIATELLA funding rounds
No funding rounds for AIATELLA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AIATELLA valuation
AIATELLA's last reported valuation was $6.1 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
AIATELLA investors
7 investors are on record for AIATELLA, including Business Finland, Harjavalta, Accelerating FemTech and Instrumentarium Science Foundation.
About AIATELLA
Developer of cloud-based medical software designed to address the global healthcare crisis of increasing imaging volumes and specialist shortages. The company offers AI systems to detect and diagnose cardiovascular disease accurately, providing healthcare professionals with tools to improve diagnostic accuracy and patient outcomes.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2022
- Employees
- 9
- Website
- aiatella.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.